Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-18

Clinical Trial Update: Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 trial exploring whether increasing testosterone improves insulin sensitivity in men with metabolic syndrome; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Metabolic Syndrome | Phase 1 | Status: TERMINATED